Literature DB >> 29377259

A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin.

Sonal Muzumdar1, Melissa Argraves1, Arni Kristjansson2, Katalin Ferenczi2, Soheil S Dadras2,3.   

Abstract

Histologic differentiation of melanoma in situ (MIS) from solar keratosis on chronically sun-damaged skin is challenging. The first-line immunostain is usually MART-1/Melan-A, which can exaggerate the epidermal melanocytes, causing a diagnostic pitfall for MIS. By comparing MART-1 and SOX10 immunostaining, we scored the percentage of epidermal melanocytes per 2-mm diameter fields in pigmented actinic keratosis (n = 16), lichenoid keratosis (n = 7), junctional melanocytic nevus (n = 6), keratosis with atypical melanocytic proliferation (n = 17) and MIS (n = 10). These cases represented an older population (68 years median age) and the head and neck (50%) was the most common anatomic site. MART-1 score was significantly higher than SOX10 (P value <.05) in solar keratoses, but showed no difference in detecting melanocytic proliferations, demonstrating their equal detection rate of melanocytes. The sensitivity of both MART-1 and SOX10 was 100%, while their specificities were 17% and 96%, respectively. These results show that SOX10 is more specific than MART-1 in distinguishing epidermal melanocytes on sun-damaged skin by avoiding overdiagnosis of melanoma.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MART-1; Melan-A; SOX10; atypical melanocytic proliferation; benign lichenoid keratosis; junctional dysplastic melanocytic nevus; melanoma in situ; pigmented actinic keratosis

Mesh:

Substances:

Year:  2018        PMID: 29377259     DOI: 10.1111/cup.13115

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  1 in total

1.  Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions.

Authors:  Sabrina E Dass; Taryn Huizenga; Mehdi Farshchian; Darius R Mehregan
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.